Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study – Hemophilia News Today
Hemophilia News Today |
Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study
Hemophilia News Today However, there are important safety risks associated with these liver-targeted therapies, because some patients start to develop an immune response against the AAV viral vector. Moreover, some patients are ineligible for this type of therapy, including … CRISPR “One Shot" Cell Therapy for Hemophilia Developed |
